/General Meetings

General Meetings

Polandplvia direct
// Job Type
Full Time
// Salary
Not disclosed
// Posted
2 weeks ago

About the Role

Home Investor Relations General Meetings Investor Relations Captor Therapeutics ® General Meetings 2026 2025 2024 2023 Annual General Meeting - 19 June 2026 text of the announcement with the agenda of the Annual General Meeting draft resolutions to be discussed at the Annual General Meeting of the Company content of the resolution of the Supervisory Board giving a positive opinion on the draft resolutions to be discussed at the Annual General Meeting of the Company remuneration report prepared by the Supervisory Board of the Company for the year 2025 independent auditor's report on the provision of a service providing reasonable assurance regarding the assessment of the remuneration report the report of the Supervisory Board of the Company for the year 2024 template of power of attorney template for instructions on exercising voting rights by proxy information on the total number of votes Submission of a candidate for membership on the Company’s Supervisory Board resume of the candidate for the Supervisory Board_A.Galazka statement_A.Galazka Submission of a candidates for membership on the Company’s Supervisory Board resume of a candidate for the Supervisory Board_P. Holstinghausen Holsten statement_P. Holstinghausen Holsten resume of a candidate for the Supervisory Board_Robert Florczykowski statement_R. Florczykowski resume of a candidate for the Supervisory Board_Chuck Kunsch statement_C.Kunsch resume of a candidate for the Supervisory Board_Krzysztof Samotij statement_K. Samotij resume of a candidate for the Supervisory Board_Maciej Wróblewski statement_M. Wróblewski Submission of a candidate for membership on the Company’s Supervisory Board resume of the candidate dor the Supervisory Board_M. Wnorowski statement_M. Wnorowski link to the webcast Extraordinary General Meeting - 2 March 2026 text of the notice with the agenda of the Extraordinary General Meeting draft resolutions opinion of the Management Board justifying the reasons for the exclusion of pre-emptive rights of existing shareholders in respect of bearer ordinary shares of series Y, and the proposed method for specimen power of attorney specimen instruction to exercise voting rights by proxy information on the total number of votes the content of the Supervisory Board's resolution approving the draft resolutions link to the webcast Extraordinary General Meeting - 22 October 2025 announcement draft of the resolutions opinion of the management board template of power of attorney instructions for voting information on the total number of votes the content of the resolution of the Supervisory Board giving the favourable opinion on the draft resolutions of the Company’s General Meeting link to the webcast draft resolution no. 4 submitted by a shareholder Annual General Meeting - 26 June 2025 announcement with the agenda of the Annual General Meeting draft resolutions to be discussed at the Annual General Meeting of the Company the content of the resolution of the Supervisory Board giving a positive opinion on the draft resolutions to be discussed at the Annual General Meeting of the Company remuneration report prepared by the Supervisory Board of the Company for the year 2024 independent auditor's report on the performance of an attestation service providing reasonable assurance on the assessment of the remuneration report of Captor Therapeutics S.A report of the Supervisory Board of the Company for the year 2024 specimen power of attorney specimen instruction to exercise voting rights by proxy information on the total number of votes link to the webcast Extraordinary General Meeting - 24.02.2025 Announcement Draft resolutions Power of Attorney PoA_instruction Information on the total number of votes Request of the Shareholder to place certain matters on the agenda of the EGM Announcement of amendment to the agenda PoA instruction taking into account the added draft resolution Opinion of the Supervisory Board link to the webcast Annual General Shareholders Meeting - 27 .06.2024 Announcement Draft resolutions The content of the resolution of the Supervisory Board giving a positive opinion on the draft resolutions The opinion of the Company's Management Board Remuneration report Independent auditor's report on the assessment of the remuneration report Report of the Supervisory Board Power of Attorney PoA_instruction Information on the total number of votes Link to the webcast resolutions adopted by the AGM on 27 June 2024 Extraordinary General Meeting - 20.03.2024 Announcement draft resolutions of the EGM Opinion of the Management Board Power of Attorney PoA_instruction Information on the total number of shares Link to the webcast Resolution of the Supervisory Board - draft resolutions of the EGM Extraordinary General Meeting - 4.01.2024 Announcement Draft resolutions Power of Attorney PoA_instruction Information on the total number of votes Link to the webcast Resolutions adopted by the EGM Extraordinary General Meeting - 5.09.2023 Ordinary Shareholders Meeting - 26.06.2023 Announcement of convening the OGM Draft resolutions Report on remuneration for 2022 Report on assessment of the Report on remuneration Report of the Supervisory Board Resolutions adopted Extraordinary General Meeting 3.04.2023 Resolutions of the Extraordinary General Meeting - 3.04.2023

Interested in this job?

Use our AI to tailor your resume for this General Meetings position at Captor Therapeutics S.A.